Critical Care Update 2021
3rd Edition
Published on 31. October 2021
Book
Paperback/Softback
458 pages
978-93-90595-87-7 (ISBN)
More details
Edition
3rd Revised edition
Language
English
Place of publication
New Delhi
India
Target group
College/higher education
Edition type
Revised edition
Dimensions
Height: 279 mm
Width: 216 mm
ISBN-13
978-93-90595-87-7 (9789390595877)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Persons
Subhash Todi MD MRCP
Director, Department of Critical Care, Advanced Medicare Research Institute, Kolkata, West Bengal, India
Deepak Govil MD EDIC FICCM FCCM
Director, Institute of Critical Care and Anesthesia, Medanta - The Medicity, Gurugram, Haryana, India
Dhruva Chaudhry MD DNB DM
Professor and Head, Department of Pulmonary and Critical Care Medicine, Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India
Subhal Bhalchandra Dixit MD IDCCM FICCM FICP FCCM
Consultant, Critical Care and Director, ICU, Department of Critical Care, Sanjeevan and MJM Hospitals, Pune, Maharashtra, India
Director, Department of Critical Care, Advanced Medicare Research Institute, Kolkata, West Bengal, India
Deepak Govil MD EDIC FICCM FCCM
Director, Institute of Critical Care and Anesthesia, Medanta - The Medicity, Gurugram, Haryana, India
Dhruva Chaudhry MD DNB DM
Professor and Head, Department of Pulmonary and Critical Care Medicine, Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India
Subhal Bhalchandra Dixit MD IDCCM FICCM FICP FCCM
Consultant, Critical Care and Director, ICU, Department of Critical Care, Sanjeevan and MJM Hospitals, Pune, Maharashtra, India
Content
Section 1: Respiratory
1 Monitoring respiratory drive in spontaneous and mechanically ventilated patients
2 Use misuse and abuse of HFNC
3 Management of complex pleural effusion in ICU
4 ARDS phenotype: Clinical relevance
5 Long term consequences of ARDS its management
6 Diffuse Parenchymal lung disease
7 Patient self-inflicted lung injury: Clinical relevance
8 Role of P.01 in difficult weaning
9 Transpulmonary pressure guided ventilation: Where do we stand?
10 VILI prevention: is mechanical power targeted therapy the ultimate goal
11 Predicting microorganism in VAP: Is Surveillance culture the answer?
12 Effect of critical care illness on sleep
Section 2: Extra corporeal life support
13 Infectious complications in patients on ECMO
14 CPR: To whom and when
15 ECMO in cardiogenic shock: When, and why and to whom?
16 Ventricular assess devices
Section 3: Hemodynamics
17 Cardiovascular coupling (ventricular atrial): everyday relevance in critical care
18 Fluid resuscitation targets in sepsis: Should we stop monitoring MAP
19 Arterial elastance: The renewed interest
20 Perfusion index by pulse oximetry: Utility in ICU
Section 4: Cardiovascular
21 ACLS 2020: What has changed
22 Refractory vasodilatory shock: What's new?
23 Optimizing diuresis in acute decompensated heart failure
24 Predicting intraoperative hypotension
Section 5: Sepsis and Septic shock
25 Vitamins in sepsis B, C, D: Current status
26 Newer antibiotics for community acquired pneumonia
27 Recent advances in diagnosis and management of Candidemia
28 Cytokine blockade: double edge sword
29 Antifungal stewardship
Section 6: Nutrition
30 Personalized feeding in septic patients
31 Risks of overfeeding in ICU
32 Protein versus calories: which is more important?
33 Muscle mass: bedside monitoring and relevance
34 Use of newer technology in ICU nutrition
Section 7: Gastroenterology
35 Diagnosis and management of AKI in liver failure
36 Diarrhoea in immunocompromised patients
37 Cryptic infections in cirrhotic patients
Section 8: USG and ECHO
38 Ultrasound assessment of weaning failure
39 POCUS in Sepsis
40 Role of ultrasound in de-resuscitation
41 Ultrasound guided ventilation
42 Lung ultrasound in COVID: Pearls and pitfalls
Section 9: Renal and electrolytes
43 Drug induced AKI
44 Hyperviscocity syndromes
45 Timing of renal replacement therapy in ICU
46 Monitoring patients on CRRT
47 Urinary electrolyte measurement: When and why
48 Emphysematous pyelonephritis
49 Renal tubular acidosis in ICU: Are we missing it?
Section 10: Neurocritical care
50 Imaging based ischemic stroke management: What should we know
51 Hypoxic ischemic encephalopathy
52 Antibiotic associated neurotoxicity
53 Autoimmune encephalitis
54 Antifibrinolytic therapy in TBI: What do we know?
55 Inhalation sedation in ICU: Is it worth all the effort?
56 Advanced directives in India: Ethical, legal and practical considerations
57 Optimizing availability and quality of cadaveric organs
58 Epidural analgesia in ICU, is it underused
Section 11: COVID related ICU issues
59 Fungal pneumonia, COVID associated fungal
60 COVID breathlessness
61 Multi system cytokine inflammatory syndrome (MCIS)
62 Convalescent plasma therapy
Section 12: Trauma/Perioperative/Toxicology/Burn
63 Perioperative delirium
64 Tranexamic acid: Current use in ICU
65 Optimising antimicrobial use in burns
66 Extracorporal Blood purification in poisoning and drug overdose
Section 13: Quality/Ethics/Organisation/ICU research
67 Communication skills: Tricks of the trade
68 Use of artificial intelligence in ICU
69 Towards safer procedures in ICU
70 Temperature monitoring in the critically ill
71 Critical care pharmacist: An unmet need
72 Post ICU follow up clinic
73 Organ donation: Current guidelines
74 Care of elderly in ICU
75 Post traumatic stress disorder
76 Iatrogenic air embolism
77 Chlorhexadine oral hygiene in ICU: Is it safe?
Section 14: Hematology/Oncology/Obstetrics /Pharmacology
78 Obstetric rapid response team
79 Iron substitution in ICU
80 Vasculitis in ICU
81 Life threatening complication of newer oncological therapies
82 Challenges in glucose monitoring in ICU
83 Detecting relative adrenal insufficiency and diabetes insipidus
1 Monitoring respiratory drive in spontaneous and mechanically ventilated patients
2 Use misuse and abuse of HFNC
3 Management of complex pleural effusion in ICU
4 ARDS phenotype: Clinical relevance
5 Long term consequences of ARDS its management
6 Diffuse Parenchymal lung disease
7 Patient self-inflicted lung injury: Clinical relevance
8 Role of P.01 in difficult weaning
9 Transpulmonary pressure guided ventilation: Where do we stand?
10 VILI prevention: is mechanical power targeted therapy the ultimate goal
11 Predicting microorganism in VAP: Is Surveillance culture the answer?
12 Effect of critical care illness on sleep
Section 2: Extra corporeal life support
13 Infectious complications in patients on ECMO
14 CPR: To whom and when
15 ECMO in cardiogenic shock: When, and why and to whom?
16 Ventricular assess devices
Section 3: Hemodynamics
17 Cardiovascular coupling (ventricular atrial): everyday relevance in critical care
18 Fluid resuscitation targets in sepsis: Should we stop monitoring MAP
19 Arterial elastance: The renewed interest
20 Perfusion index by pulse oximetry: Utility in ICU
Section 4: Cardiovascular
21 ACLS 2020: What has changed
22 Refractory vasodilatory shock: What's new?
23 Optimizing diuresis in acute decompensated heart failure
24 Predicting intraoperative hypotension
Section 5: Sepsis and Septic shock
25 Vitamins in sepsis B, C, D: Current status
26 Newer antibiotics for community acquired pneumonia
27 Recent advances in diagnosis and management of Candidemia
28 Cytokine blockade: double edge sword
29 Antifungal stewardship
Section 6: Nutrition
30 Personalized feeding in septic patients
31 Risks of overfeeding in ICU
32 Protein versus calories: which is more important?
33 Muscle mass: bedside monitoring and relevance
34 Use of newer technology in ICU nutrition
Section 7: Gastroenterology
35 Diagnosis and management of AKI in liver failure
36 Diarrhoea in immunocompromised patients
37 Cryptic infections in cirrhotic patients
Section 8: USG and ECHO
38 Ultrasound assessment of weaning failure
39 POCUS in Sepsis
40 Role of ultrasound in de-resuscitation
41 Ultrasound guided ventilation
42 Lung ultrasound in COVID: Pearls and pitfalls
Section 9: Renal and electrolytes
43 Drug induced AKI
44 Hyperviscocity syndromes
45 Timing of renal replacement therapy in ICU
46 Monitoring patients on CRRT
47 Urinary electrolyte measurement: When and why
48 Emphysematous pyelonephritis
49 Renal tubular acidosis in ICU: Are we missing it?
Section 10: Neurocritical care
50 Imaging based ischemic stroke management: What should we know
51 Hypoxic ischemic encephalopathy
52 Antibiotic associated neurotoxicity
53 Autoimmune encephalitis
54 Antifibrinolytic therapy in TBI: What do we know?
55 Inhalation sedation in ICU: Is it worth all the effort?
56 Advanced directives in India: Ethical, legal and practical considerations
57 Optimizing availability and quality of cadaveric organs
58 Epidural analgesia in ICU, is it underused
Section 11: COVID related ICU issues
59 Fungal pneumonia, COVID associated fungal
60 COVID breathlessness
61 Multi system cytokine inflammatory syndrome (MCIS)
62 Convalescent plasma therapy
Section 12: Trauma/Perioperative/Toxicology/Burn
63 Perioperative delirium
64 Tranexamic acid: Current use in ICU
65 Optimising antimicrobial use in burns
66 Extracorporal Blood purification in poisoning and drug overdose
Section 13: Quality/Ethics/Organisation/ICU research
67 Communication skills: Tricks of the trade
68 Use of artificial intelligence in ICU
69 Towards safer procedures in ICU
70 Temperature monitoring in the critically ill
71 Critical care pharmacist: An unmet need
72 Post ICU follow up clinic
73 Organ donation: Current guidelines
74 Care of elderly in ICU
75 Post traumatic stress disorder
76 Iatrogenic air embolism
77 Chlorhexadine oral hygiene in ICU: Is it safe?
Section 14: Hematology/Oncology/Obstetrics /Pharmacology
78 Obstetric rapid response team
79 Iron substitution in ICU
80 Vasculitis in ICU
81 Life threatening complication of newer oncological therapies
82 Challenges in glucose monitoring in ICU
83 Detecting relative adrenal insufficiency and diabetes insipidus